Source comparison
TB-500 Tennis Elbow: Peptide vs Conventional Treatment Comparison
TB-500 Protocol Actin regulation + angiogenesis + cytokine modulation 3–6 weeks (cellular remodeling phase) Increases collagen deposition, enhances vascularity, improves tensile strength Low (addresses root cause) Best option for chronic cases unresponsive to
This comparison does not assign a generated winner or score.
- TB-500 Protocol
- Actin regulation + angiogenesis + cytokine modulation
- 3–6 weeks (cellular remodeling phase)
- Increases collagen deposition, enhances vascularity, improves tensile strength
- Low (addresses root cause)
- Best option for chronic cases unresponsive to conservative therapy. Requires patience for structural repair
- Corticosteroid Injection
- Suppresses inflammatory cascade (COX-2, prostaglandins)
- 48–72 hours (symptom relief)
- Inhibits fibroblast proliferation, reduces collagen synthesis, causes temporary tissue weakening
- High (40–60% within 12 months)
- Effective for acute symptom relief but contraindicated for repeated use. Degrades tendon integrity
- NSAID Therapy
- COX enzyme inhibition (reduces prostaglandin synthesis)
- 7–14 days (pain reduction)
- No direct effect on tendon repair; may impair healing if used long-term
- Moderate (symptoms return when mechanical stress resumes)
- Symptomatic relief only. Does not address degenerative tendon changes
- Eccentric Exercise Protocol
- Mechanical loading stimulates collagen realignment and fibroblast activation
- 6–12 weeks (gradual strength improvement)
- Improves tendon tensile strength and cross-sectional area when performed correctly
- Low (evidence-based first-line treatment)
- Gold standard conservative approach. Works best when combined with modalities addressing vascularity
- Platelet-Rich Plasma (PRP)
- Growth factor delivery (PDGF, TGF-β, IGF-1) via autologous platelets
- 4–8 weeks (variable response)
- Stimulates collagen synthesis and angiogenesis; results highly preparation-dependent
- Moderate (depends on preparation quality)
- Promising but inconsistent. Success tied to platelet concentration and preparation protocol
- The comparison underscores a fundamental divide: treatments that suppress symptoms versus those that rebuild tissue. TB-500 sits in the latter category alongside eccentric exercise and PRP, but its mechanism is more targeted than either. It doesn't rely on patient compliance (like eccentric protocols) or preparation variability (like PRP). It delivers a single molecular signal that diseased tendon tissue responds to predictably.